The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02793934 |
Recruitment Status : Unknown
Verified April 2018 by St. Petersburg State Pavlov Medical University.
Recruitment status was: Recruiting
First Posted : June 8, 2016
Last Update Posted : April 26, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Programme is focused on adult patients of any gender and age more than 18 y.o., with the next conditions:
- Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage - specialty neurology)
- Acute myocardial infarction (AMI, specialty cardiology)
- Patients after total hip replacement (THR, specialty orthopaedia) The program is performed in the in-patient and out-patient rehabilitation departments in 13 regions of the Russian Federation (total 244 departments).
Condition or disease | Intervention/treatment |
---|---|
Stroke AMI Total Hip Replacement | Other: Scales Other: New model of rehabilitation Other: Old model of rehabilitation Other: ICF reader |

Study Type : | Observational |
Estimated Enrollment : | 2000 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | The Development Of MEdical Rehabilitation inRussia Pilot Project |
Study Start Date : | September 2015 |
Estimated Primary Completion Date : | September 2020 |
Estimated Study Completion Date : | December 2020 |

Group/Cohort | Intervention/treatment |
---|---|
1st phase
In the 1st phase of the study the staff of the medical organizations continue to work in the familiar "old" scheme, but using the set of scales.
|
Other: Scales
For stroke patients there are used scales: Modified Rankin Scale, NIH Stroke Scale , Glasgow Coma Scale, Dysphagia Severity, Rating Scale Speech or Language Impairment Severity Rating Scale, Modified Rivermead Mobility Index, Berg Balance Scale, Modified Ashworth Scale, Medical Research Council Scale, Frenchay Arm Test, Montreal Cognitive Assessment Scale, Spielberger Scale, Beck's Depression Inventory, Visual Analogue Scale, Functional Independence Measure For patients after AMI: Rankin scale, GRACE scale, MoCA, VAS, Hospital scale of anxiety and depression, Canadian classification if stenocardia For patients after THR: The pain of the operated joint on VAS scores The Harris scale (the total amount), Scale Lequesne (total), Hospital scale of anxiety Other: Old model of rehabilitation Other: ICF reader |
2nd phase
In the 2nd phase, medical organizations will start to work on a new model with the implementation of problem-oriented multidisciplinary approach and the use of modern rehabilitation technologies. There is planning to use clearly defined criteria for transfer from stage to stage, developed by the professional community. When doctors will be trained program "ICF-reader" will have an opportunity to establish a rehabilitation diagnosis on the basis of the ICF, and the option for ICF assessment using rating scales.
|
Other: Scales
For stroke patients there are used scales: Modified Rankin Scale, NIH Stroke Scale , Glasgow Coma Scale, Dysphagia Severity, Rating Scale Speech or Language Impairment Severity Rating Scale, Modified Rivermead Mobility Index, Berg Balance Scale, Modified Ashworth Scale, Medical Research Council Scale, Frenchay Arm Test, Montreal Cognitive Assessment Scale, Spielberger Scale, Beck's Depression Inventory, Visual Analogue Scale, Functional Independence Measure For patients after AMI: Rankin scale, GRACE scale, MoCA, VAS, Hospital scale of anxiety and depression, Canadian classification if stenocardia For patients after THR: The pain of the operated joint on VAS scores The Harris scale (the total amount), Scale Lequesne (total), Hospital scale of anxiety Other: New model of rehabilitation Other: ICF reader |
- Mortality [ Time Frame: through study completion, an average of 1 month ]
- Recovery of functions, activity and participation [ Time Frame: through study completion, an average of 1 month ]modified Renkin scale)
- Mortality [ Time Frame: 90 days after discharge ]
- Recovery of functions, activity and participation [ Time Frame: 90 days after discharge ]
- Environmental adaptation [ Time Frame: 90 days after discharge ]
- Preventable conditions [ Time Frame: 90 days after discharge ]Pain Trophic disturbances Muscle tonus disturbances Contractures Cognitive disorders Inadequate tolerance Social disadaptation etc
- Time of start of rehabilitation [ Time Frame: through study completion, an average of 1 month ]
- Time of the first, interim and final expert assessment of rehabilitation potential [ Time Frame: through study completion, an average of 1 month ]
- Duration of hospitalization [ Time Frame: through study completion, an average of 1 month ]
- Duration of rehabilitation process for the achievement the goals for each stage of rehabilitation [ Time Frame: through study completion, an average of 1 month ]
- Duration of rehabilitation process from onset of disease to final or to transfer the patient or to establishing the disability [ Time Frame: through study completion, an average of 1 month ]
- Criteria of rehabilitation potential [ Time Frame: up to 6 months ]
- Criteria for the transferring to the next stage or to another hospital [ Time Frame: up to 6 months ]
- Case mix groups on basic functional disturbances (by ICF) [ Time Frame: up to 6 months ]
- Criteria for the transferring to the palliative or nursing care [ Time Frame: up to 6 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
The Programme is focused on adult patients of any gender and age more than 18 y.o., with the next conditions:
Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage - specialty neurology) Acute myocardial infarction (AMI, specialty cardiology) Patients after total hip replacement (THR, specialty orthopaedia)
Inclusion Criteria:
- Age over 18 years old
- Ischemic stroke or intracerebral hemorrhage
- Patients with acute myocardial infarction with elevation of segment ST (STMI)
- Total hip replacement caused by degenerative processes
Exclusion Criteria:
- uncorrected metabolic diseases (diabetes mellitus, myxoedema, thyrotoxicosis);
- III hepatic or pancreatic insufficiency
- heavy or repeated hemorrhages of any reason or anaemia Hb<80g/l;
- parasitoses;
- acute infectious disease;
- active stage of any form of tuberculosis;
- patients with transmissible sexual diseases;
- mental illness with personality desocialisation;
- complicate ventricular rhythm disturbances
- high risk of thromboembolism
- absence of motivation
- decompensation of somatic functions

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02793934
Contact: Ivanova Galina, Professor | +79161144504 | reabiivanova@mail.ru | |
Contact: Melnikova Elena, Professor | +7 (911) 743-15-08 | melnikovae2002@mail.ru |
Russian Federation | |
StPetersburgSPMU | Recruiting |
Saint Petersburg, Russian Federation, 197022 | |
Contact: Elena V. Melnikova, MD, Ph.D +7117431508 melnikovae2002@gmail.com | |
Contact: Alexey A. Shmonin, Ph.D +79213568136 langendorff@gmail.com |
Principal Investigator: | Shmonin Alexey, PhD | St. Petersburg State Pavlov Medical University | |
Principal Investigator: | Shamalov Nikolay, Professor | Pirogov Russian National Medical Research University | |
Principal Investigator: | Suvorov Andrey, PhD | Pirogov Russian National Medical Research University | |
Principal Investigator: | Buylova Tatiana, Professor | Rehabilitation Center of Federal State Unitary Enterprise Nizhegorodskoye PROP | |
Principal Investigator: | Tsykunov Mikhail, Professor | Central Research Institute of Traumatology and Orthopedics . Priorov Russian Ministry of Health | |
Principal Investigator: | Belyaev Anatoliy, Professor | Vladivostok State Medical University | |
Principal Investigator: | Prokopenko Sergei, Professor | Krasnoyarsk State Medical University named after Prof. V.F.Voino-Yasenetsky | |
Principal Investigator: | Khasanova Dina, Professor | Kazan State Medical University Russian Ministry of Health | |
Principal Investigator: | Bodrova Rezeda, PhD | Kazan State Medical Academy | |
Principal Investigator: | Aronov David, Professor | State Research Center for Preventive Medicine Health Ministry of Russia | |
Principal Investigator: | Bubnova Marina, Professor | State Research Center for Preventive Medicine Health Ministry of Russia | |
Principal Investigator: | Belkin Anatoliy, Professor | Ural State Medical University Russian Ministry of Health | |
Principal Investigator: | Mishina Irina, Professor | Ivanovo State Medical Academy Russian Ministry of Health | |
Principal Investigator: | Sarana Andrey, PhD | Saint-Petersburg City Hospital № 40 of Recreation Area | |
Principal Investigator: | Ivanova Natalya, Professor | Russian Research Neurosurgical Polenovs Institute | |
Principal Investigator: | Yashkov Alexander, Professor | Samara State Medical University | |
Principal Investigator: | Maltseva Mariya, Professor | St. Petersburg State Pavlov Medical University | |
Principal Investigator: | Soloveva Liudmila, MD | St. Petersburg State Pavlov Medical University |
Publications of Results:
Responsible Party: | St. Petersburg State Pavlov Medical University |
ClinicalTrials.gov Identifier: | NCT02793934 |
Other Study ID Numbers: |
DOME |
First Posted: | June 8, 2016 Key Record Dates |
Last Update Posted: | April 26, 2018 |
Last Verified: | April 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Rehabilitation ICF Pilot project |
Stroke Acute myocardial infarction Total hip replacement |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |